ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,411,000 | +84.4% | 30,440 | -3.1% | 0.16% | +79.5% |
| Q1 2019 | $765,000 | +66.3% | 31,400 | -2.8% | 0.09% | +46.7% |
| Q4 2018 | $460,000 | -6.3% | 32,300 | 0.0% | 0.06% | +13.2% |
| Q3 2018 | $491,000 | -9.4% | 32,300 | 0.0% | 0.05% | -15.9% |
| Q2 2018 | $542,000 | +6.1% | 32,300 | +3.0% | 0.06% | +3.3% |
| Q1 2018 | $511,000 | +20.8% | 31,350 | -5.0% | 0.06% | +17.3% |
| Q4 2017 | $423,000 | +2.4% | 33,000 | -1.8% | 0.05% | -1.9% |
| Q3 2017 | $413,000 | +47.0% | 33,600 | 0.0% | 0.05% | +39.5% |
| Q2 2017 | $281,000 | -11.9% | 33,600 | -5.9% | 0.04% | -15.6% |
| Q1 2017 | $319,000 | +1.9% | 35,700 | 0.0% | 0.04% | -6.2% |
| Q4 2016 | $313,000 | +29.9% | 35,700 | 0.0% | 0.05% | +26.3% |
| Q3 2016 | $241,000 | +88.3% | 35,700 | 0.0% | 0.04% | +72.7% |
| Q2 2016 | $128,000 | +21.9% | 35,700 | 0.0% | 0.02% | +22.2% |
| Q1 2016 | $105,000 | -30.5% | 35,700 | 0.0% | 0.02% | -33.3% |
| Q4 2015 | $151,000 | -7.4% | 35,700 | 0.0% | 0.03% | -12.9% |
| Q3 2015 | $163,000 | -36.8% | 35,700 | 0.0% | 0.03% | -31.1% |
| Q2 2015 | $258,000 | -1.9% | 35,700 | 0.0% | 0.04% | -2.2% |
| Q1 2015 | $263,000 | +52.9% | 35,700 | -2.2% | 0.05% | +48.4% |
| Q4 2014 | $172,000 | +31.3% | 36,500 | 0.0% | 0.03% | +29.2% |
| Q3 2014 | $131,000 | -21.6% | 36,500 | 0.0% | 0.02% | -22.6% |
| Q2 2014 | $167,000 | -2.9% | 36,500 | 0.0% | 0.03% | -11.4% |
| Q1 2014 | $172,000 | -6.0% | 36,500 | 0.0% | 0.04% | -2.8% |
| Q4 2013 | $183,000 | -19.4% | 36,500 | 0.0% | 0.04% | -28.0% |
| Q3 2013 | $227,000 | +36.7% | 36,500 | 0.0% | 0.05% | +25.0% |
| Q2 2013 | $166,000 | – | 36,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |